A Focus on Multiple Sclerosis

Published August 8, 2012

A Focus on Multiple Sclerosis – Doug Schell, from the MidAmerica Neuroscience Institute, explains why the institute has specifically focused a large portion of our efforts on helping patients affected by Multiple Sclerosis. The MidAmerica Neuroscience Institute is online at: www.neurokc.com and can be reached via phone at (913) 894-1500.

Pa. teen sent to treatment facility in son's death

Filed under: Kansas City Drug Rehab Centers

An eastern Pennsylvania teenager who pleaded guilty in the drowning death of her newborn son has been ordered placed indefinitely in a treatment facility. The Reading Eagle ( http://bit.ly/MrqGQW) says 16-year-old Angela Lightcap of Greenwich Township …
Read more on Sacramento Bee

Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended …

Filed under: Kansas City Drug Rehab Centers

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and …
Read more on Sacramento Bee

Rigel Announces Second Quarter 2012 Financial Results

Filed under: Kansas City Drug Rehab Centers

Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses …
Read more on Sacramento Bee